- the University of Hong Kong
- Hong Kong
About SUN JIERAN
I am a/an:
Area of Expertise
Channels contributed to:News & Events Arts & Humanities Medicine & Health STEM
Rooms participated in:Medicine & Health
This is awesome! Miscommunication can easily be the greatest barrier to medical research translation.
Hi Sun, this is such a great informative article. I was wondering if you think these 3D printing processes could be scaled up and whether this is currently possible or will require further developments in the field?
Hi James. Thanks for the question. Scaling is, without doubt, an important issue for the manufacture of 3D printing techniques. Yet I think to answer your questions from my understanding, there are no obvious technical difficulties for the relatively fast and convenient printing processes of drug tablets. Yet as a newly-emerged technique, the companies are still seeking partners to prepare for the initial commercial-scale manufacturing given the specific requirements for the manufacturing environment and 3D printers.
Many of those drug-printing techniques focused on rare diseases as they provide more flexibilities with lower cost. That, to some extent, may also be related to the fact that the newborn techniques are looking for a way to enter the market, even with some printed drugs approved by the FDA.
Lemme know your thoughts! :))